المؤلفون: Lacher SB; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Dörr J; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., de Almeida GP; Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, TUM, Freising, Germany., Hönninger J; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, TUM, Munich, Germany., Bayerl F; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Hirschberger A; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Pedde AM; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Meiser P; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Ramsauer L; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Rudolph TJ; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Spranger N; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and UNIL, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and UNIL, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Jarosch S; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, TUM, Munich, Germany.; Boehringer Ingelheim, Biberach, Germany., Oner A; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Gregor L; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Lesch S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Michaelides S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Fertig L; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Briukhovetska D; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Majed L; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany., Stock S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital, Munich, Germany., Busch DH; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, TUM, Munich, Germany., Buchholz VR; Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, TUM, Munich, Germany., Knolle PA; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Zehn D; Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, TUM, Freising, Germany., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and UNIL, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Kobold S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany., Böttcher JP; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany. j.boettcher@tum.de.

المصدر: Nature [Nature] 2024 May; Vol. 629 (8011), pp. 417-425. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/cytology , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Cell Proliferation* , Dinoprostone*/metabolism , Lymphocytes, Tumor-Infiltrating*/cytology , Lymphocytes, Tumor-Infiltrating*/immunology , Lymphocytes, Tumor-Infiltrating*/metabolism , Neoplasms*/immunology , Neoplasms*/prevention & control , Stem Cells*/cytology , Stem Cells*/immunology , Stem Cells*/metabolism , Tumor Escape*/immunology, Animals ; Female ; Humans ; Male ; Mice ; Cell Differentiation ; Cell Line, Tumor ; Disease Models, Animal ; Hepatocyte Nuclear Factor 1-alpha/metabolism ; Interleukin-2 ; Lymph Nodes/cytology ; Lymph Nodes/immunology ; Mice, Inbred C57BL ; Receptors, Prostaglandin E, EP2 Subtype/deficiency ; Receptors, Prostaglandin E, EP2 Subtype/metabolism ; Receptors, Prostaglandin E, EP4 Subtype/deficiency ; Receptors, Prostaglandin E, EP4 Subtype/metabolism ; Signal Transduction

المؤلفون: Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Hope HC; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Desbuisson M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Rayroux N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Masid M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Murgues B; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Chap BS; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ongaro M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Rota IA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ronet C; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Minasyan A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Lacher SB; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Murgues C; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Ghisoni E; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ouchen K; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Bou Mjahed R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Abdellaoui N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Turrini R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland., Gannon PO; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Zaman K; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Mathevet P; Department of Gynaecology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Lelievre L; Department of Gynaecology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Conrad M; Institute of Metabolism and Cell Death, Molecular Target and Therapeutics Centre, Helmholtz Munich, Neuherberg, Germany., Verdeil G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Kandalaft LE; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Doucey MA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland., Ho PC; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Vannini N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Böttcher JP; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland. denarda.dangaj@chuv.ch.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. denarda.dangaj@chuv.ch.; Agora Cancer Research Center, Lausanne, Switzerland. denarda.dangaj@chuv.ch., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland. george.coukos@chuv.ch.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. george.coukos@chuv.ch.; Agora Cancer Research Center, Lausanne, Switzerland. george.coukos@chuv.ch.

المصدر: Nature [Nature] 2024 May; Vol. 629 (8011), pp. 426-434. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/cytology , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Cell Proliferation* , Dinoprostone*/metabolism , Interleukin-2*/antagonists & inhibitors , Interleukin-2*/immunology , Interleukin-2*/metabolism , Lymphocytes, Tumor-Infiltrating*/cytology , Lymphocytes, Tumor-Infiltrating*/immunology , Lymphocytes, Tumor-Infiltrating*/metabolism , Mitochondria*/metabolism , Signal Transduction*, Animals ; Humans ; Mice ; Down-Regulation ; Ferroptosis ; Interleukin Receptor Common gamma Subunit/biosynthesis ; Interleukin Receptor Common gamma Subunit/deficiency ; Interleukin Receptor Common gamma Subunit/metabolism ; Interleukin-2 Receptor beta Subunit/metabolism ; Oxidative Stress ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism ; Receptors, Prostaglandin E, EP2 Subtype/metabolism ; Receptors, Prostaglandin E, EP2 Subtype/antagonists & inhibitors ; Receptors, Prostaglandin E, EP4 Subtype/metabolism ; Receptors, Prostaglandin E, EP4 Subtype/antagonists & inhibitors ; TOR Serine-Threonine Kinases/metabolism ; Tumor Microenvironment/immunology

المؤلفون: Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Ghisoni E; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Orcurto A; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland., Fahr N; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland., Zimmermann S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Duran R; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland., Imbimbo M; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., de Olza MO; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Navarro B; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Homicsko K; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Labes D; Flow Cytometry Facility, Department of Formation and Research, University of Lausanne, Epalinges, Switzerland., Tsourti Z; Scientific Research Consulting Hellas, Athens, Greece., Andriakopoulou C; Scientific Research Consulting Hellas, Athens, Greece., Herrera F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Service of Radiation Oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Pétremand R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Berthod G; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Kraemer AI; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Huber F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Thevenet J; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Schaefer N; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Prior JO; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Matter M; Department of Visceral Surgery, Lausanne University Hospital, and University of Lausanne, Lausannne, Switzerland., Aedo V; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dromain C; Department of Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland., Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Tissot S; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Department of Oncology, Center of Experimental Therapeutics, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Gottardo R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Biomedical Data Science Center and Swiss Institute of Bioinformatics, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Pittet M; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Sempoux C; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland., Michielin O; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dafni U; Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece., Trueb L; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Laniti DD; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.; Service of Immuno-oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.

المصدر: Science immunology [Sci Immunol] 2024 Feb 02; Vol. 9 (92), pp. eadg7995. Date of Electronic Publication: 2024 Feb 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive* , Melanoma*/genetics, Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Proteomics ; CD8-Positive T-Lymphocytes/metabolism ; Tumor Microenvironment

المؤلفون: Duraiswamy J; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Turrini R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Minasyan A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland; Bioinformatics Core Facility, Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Casado J; Research Program of Systems Oncology, University of Helsinki, 00014 Helsinki, Finland., Genolet R; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Wicky A; Center for Precision Oncology, Department of Oncology, CHUV, 1011 Lausanne, Switzerland., Ioannidou K; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Castro W; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Neal C; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Moriot A; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Renaud-Tissot S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland; Center of Experimental Therapeutics, Department of Oncology, CHUV, 1011 Lausanne, Switzerland., Anstett V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Fahr N; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Tanyi JL; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Eiva MA; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Jacobson CA; Harvard Ludwig Center, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Montone KT; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Westergaard MCW; National Center for Cancer Immune Therapy, Copenhagen University Hospital, 2730 Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy, Copenhagen University Hospital, 2730 Herlev, Denmark., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland; Center of Experimental Therapeutics, Department of Oncology, CHUV, 1011 Lausanne, Switzerland., Delorenzi M; Bioinformatics Core Facility, Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland; Department of Oncology, UNIL, 1011 Lausanne, Switzerland., Sorger PK; Harvard Ludwig Center, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Färkkilä A; Research Program of Systems Oncology, University of Helsinki, 00014 Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Hospital, 00014 Helsinki, Finland., Michielin O; Center for Precision Oncology, Department of Oncology, CHUV, 1011 Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Carmona SJ; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Foukas PG; 2nd Department of Pathology, National and Kapodistrian University of Athens, 15771 Athens, Greece., Powell DJ Jr; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Rusakiewicz S; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland; Center of Experimental Therapeutics, Department of Oncology, CHUV, 1011 Lausanne, Switzerland., Doucey MA; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland. Electronic address: george.coukos@chuv.ch.

المصدر: Cancer cell [Cancer Cell] 2021 Dec 13; Vol. 39 (12), pp. 1623-1642.e20. Date of Electronic Publication: 2021 Nov 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Antigen-Presenting Cells/*metabolism , CD28 Antigens/*metabolism , Immune Checkpoint Inhibitors/*therapeutic use , Myeloid Cells/*metabolism , Neoplasms/*drug therapy , Stem Cell Niche/*genetics, Humans ; Immune Checkpoint Inhibitors/pharmacology ; Neoplasms/immunology

المؤلفون: Martin-Lluesma S; Center of Experimental Therapeutics, Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland., Graciotti M; Vaccine Development Laboratory, Ludwig Center for Cancer Research, University of Lausanne, Lausanne 1011, Switzerland., Grimm AJ; Center of Experimental Therapeutics, Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland., Boudousquié C; Center of Experimental Therapeutics, Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland., Chiang CL; Vaccine Development Laboratory, Ludwig Center for Cancer Research, University of Lausanne, Lausanne 1011, Switzerland., Kandalaft LE; Center of Experimental Therapeutics, Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, Lausanne 1011, Switzerland; Vaccine Development Laboratory, Ludwig Center for Cancer Research, University of Lausanne, Lausanne 1011, Switzerland. Electronic address: Lana.Kandalaft@chuv.ch.

المصدر: Current opinion in biotechnology [Curr Opin Biotechnol] 2020 Oct; Vol. 65, pp. 190-196. Date of Electronic Publication: 2020 Apr 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9100492 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0429 (Electronic) Linking ISSN: 09581669 NLM ISO Abbreviation: Curr Opin Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines*/therapeutic use , Ovarian Neoplasms*/therapy , Vaccines*, Dendritic Cells ; Female ; Humans ; Immunotherapy

المؤلفون: Adams SF; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA., Grimm AJ; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Chiang CL; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Mookerjee A; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Flies D; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA., Jean S; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., McCann GA; Division of Gynecologic Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Michaux J; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Pak H; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Huber F; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Neal C; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Dangaj D; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Bassani-Sternberg M; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Rusakiewicz S; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Facciabene A; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Coukos G; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland., Gimotty PA; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kandalaft LE; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland Lana.Kandalaft@chuv.ch.; Ludwig Institute for Cancer Research, Lausanne, Switzerland.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Aug; Vol. 8 (2).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Ascites/*physiopathology , Cancer Vaccines/*immunology , Monocytes/*metabolism , Ovarian Neoplasms/*immunology , Toll-Like Receptors/*immunology, Animals ; Female ; Humans ; Mesothelin ; Mice ; Ovarian Neoplasms/mortality ; Survival Analysis

المؤلفون: Dangaj D; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Bruand M; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Ronet C; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Barras D; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland., Duttagupta PA; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; University of Chicago, Knapp Center for Biomedical Discovery, Department of Hematology & Oncology, Chicago, IL 60637, USA., Lanitis E; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Duraiswamy J; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Cell and Gene Therapy, OTAT/CBER/FDA, Silver Spring, MD 20993, USA., Tanyi JL; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Benencia F; Russ College of Engineering and Technology, Ohio University, Athens, OH 45701, USA., Conejo-Garcia J; Department of Immunology and Gynecologic Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Ramay HR; SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland; International Microbiome Centre, University of Calgary, Calgary, AB, Canada., Montone KT; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Powell DJ Jr; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Gimotty PA; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Facciabene A; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Jackson DG; Bristol-Myers Squibb, Princeton, NJ 08540, USA., Weber JS; Laura and Isaac Perlmutter Cancer Center, New York University, 522 First Avenue, Room 1310 Smilow Building, New York, NY 10016, USA., Rodig SJ; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02215, USA; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Hodi SF; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Kandalaft LE; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Irving M; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Zhang L; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Foukas P; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland; 2nd Department of Pathology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens 12464, Greece., Rusakiewicz S; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland., Delorenzi M; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland., Coukos G; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne 1066, Switzerland. Electronic address: george.coukos@chuv.ch.

المصدر: Cancer cell [Cancer Cell] 2019 Jun 10; Vol. 35 (6), pp. 885-900.e10.

نوع المنشور: Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Chemotaxis, Leukocyte*/drug effects , Lymphocyte Activation*/drug effects, CD8-Positive T-Lymphocytes/*metabolism , Cytokines/*metabolism , Dendritic Cells/*metabolism , Lymphocytes, Tumor-Infiltrating/*metabolism , Macrophages/*metabolism , Ovarian Neoplasms/*metabolism, Animals ; Antineoplastic Agents, Immunological/pharmacology ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; Cell Line, Tumor ; Chemokine CCL5/genetics ; Chemokine CCL5/immunology ; Chemokine CCL5/metabolism ; Chemokine CXCL9/genetics ; Chemokine CXCL9/immunology ; Chemokine CXCL9/metabolism ; Coculture Techniques ; Cytokines/genetics ; Cytokines/immunology ; DNA Methylation ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Epigenesis, Genetic ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunotherapy/methods ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Interferon-gamma/metabolism ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Macrophages/drug effects ; Macrophages/immunology ; Mice, Inbred C57BL ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/therapy ; Paracrine Communication ; Receptors, CXCR3/genetics ; Receptors, CXCR3/immunology ; Receptors, CXCR3/metabolism ; Signal Transduction

المؤلفون: Pinkevych M, Cromer D, Tolstrup M, Grimm AJ, Cooper DA, Lewin SR, Søgaard OS, Rasmussen TA, Kent SJ, Kelleher AD, Davenport MP

المصدر: PLoS pathogens [PLoS Pathog] 2016 Aug 25; Vol. 12 (8), pp. e1005745. Date of Electronic Publication: 2016 Aug 25 (Print Publication: 2016).

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog

المؤلفون: Julier Z; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland., de Titta A; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland., Grimm AJ; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland., Simeoni E; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland., Swartz MA; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Institute for Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA., Hubbell JA; Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Institute for Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA. Electronic address: jhubbell@uchicago.edu.

المصدر: Vaccine [Vaccine] 2016 May 05; Vol. 34 (21), pp. 2453-2459. Date of Electronic Publication: 2016 Mar 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*immunology , Fibronectins/*immunology , Hepatitis B Vaccines/*immunology , Oligodeoxyribonucleotides/*immunology , T-Lymphocytes, Cytotoxic/*immunology , Th1 Cells/*immunology , Toll-Like Receptor 4/*agonists, Adjuvants, Immunologic/administration & dosage ; Animals ; Cancer Vaccines/administration & dosage ; Dendritic Cells/immunology ; Disease Models, Animal ; Fibronectins/chemistry ; Hepatitis B/immunology ; Hepatitis B/virology ; Hepatitis B Vaccines/administration & dosage ; Hepatitis B virus/immunology ; Immunity, Cellular ; Immunity, Humoral ; Mice ; Mice, Transgenic ; Receptors, Pattern Recognition ; Toll-Like Receptor 4/immunology ; Toll-Like Receptor 9/agonists ; Toll-Like Receptor 9/immunology ; Vaccination

المؤلفون: Cromer D; Infection Analytics Program, Kirby Institute, UNSW Australia, Sydney NSW 2052, Australia. d.cromer@unsw.edu.au.; Centre for Vascular Research, UNSW Australia, Sydney NSW 2052, Australia. d.cromer@unsw.edu.au., Schlub TE; Sydney School of Public Health, Sydney Medical School, University of Sydney, Sydney NSW 2006, Australia. tim.schlub@sydney.edu.au., Smyth RP; Centre for Virology, Burnet Institute, Melbourne VIC 3004, Australia. r.smyth@ibmc-cnrs.unistra.fr.; Architecture et Réactivité de l'ARN, IBMC, CNRS, Université de Strasbourg, 67084 Strasbourg, France. r.smyth@ibmc-cnrs.unistra.fr., Grimm AJ; Infection Analytics Program, Kirby Institute, UNSW Australia, Sydney NSW 2052, Australia. andrew.j.grimm@gmail.com., Chopra A; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Perth WA 6150, Australia. a.chopra@iiid.com.au., Mallal S; Institute for Immunology and Infectious Diseases (IIID), Murdoch University, Perth WA 6150, Australia. S.Mallal@iiid.com.au., Davenport MP; Infection Analytics Program, Kirby Institute, UNSW Australia, Sydney NSW 2052, Australia. mdavenport@kirby.unsw.edu.au.; Centre for Vascular Research, UNSW Australia, Sydney NSW 2052, Australia. mdavenport@kirby.unsw.edu.au., Mak J; Biosecurity Flagship, CSIRO (AAHL), Geelong VIC 3220, Australia. johnson.mak@deakin.edu.au.; School of Medicine, Deakin University and CSIRO (AAHL), Geelong VIC 3216, Australia. johnson.mak@deakin.edu.au.

المصدر: Viruses [Viruses] 2016 Apr 22; Vol. 8 (4), pp. 118. Date of Electronic Publication: 2016 Apr 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: Mutation* , Recombination, Genetic*, HIV-1/*genetics , Macrophages/*virology , T-Lymphocytes/*virology, Algorithms ; Cell Line ; Cells, Cultured ; Evolution, Molecular ; HIV Infections/virology ; HIV-1/immunology ; Humans ; Macrophages/immunology ; Macrophages/metabolism ; Models, Theoretical ; Mutation Rate ; Receptors, CCR5/metabolism ; Receptors, CXCR4/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Virus Replication